{"version":"1.0","provider_name":"Brakke Consulting\u306e\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8","provider_url":"https:\/\/brakkeconsulting.com\/ja","title":"News from Brakke Consulting","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"e7m89X5QDT\"><a href=\"https:\/\/brakkeconsulting.com\/ja\/animal-health-news-notes-for-april-20-2018\/\">2018 \u5e74 4 \u6708 20 \u65e5\u306e\u52d5\u7269\u306e\u5065\u5eb7\u306b\u95a2\u3059\u308b\u30cb\u30e5\u30fc\u30b9\u3068\u30ce\u30fc\u30c8<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/brakkeconsulting.com\/ja\/animal-health-news-notes-for-april-20-2018\/embed\/#?secret=e7m89X5QDT\" width=\"600\" height=\"338\" title=\"&#8220;Animal Health News &#038; Notes for April 20, 2018&#8221; &#8212; Brakke Consulting Website\" data-secret=\"e7m89X5QDT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/brakkeconsulting.com\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>","description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for April 20, 2018 Copyright \u00a9 Brakke Consulting, Inc. Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting news Transaction assistance other news Alivira Animal Health Bay Medical Solutions Bremer Pharma C.J. Foods CannTrust Holdings Dechra Veterinary Products (Redonyl) Dechra Veterinary Products (PVC) Elanco FibreCycle Grey Wolf Animal Health IDT Biologika Kemin Nutrisurance Kent Pet Group Lortscher Animal Nutrition Med Vets Inc PetIQ PharmAust Piensos Unzu\u00e9 Royal De Heus Stone Mfg. VIP Petcare Holdings Zydus Cadila *********************************** BRAKKE CONSULTING, INC. TRANSACTION ASSISTANCE Buying, selling or merging? We can help! Brakke Consulting assists many clients with mergers, acquisitions and divestitures. Our transaction experts can provide the insight, ability and contacts you need in the animal health, pet, veterinary and specialty chemicals markets. Please contact any of our offices for a confidential consultation. www.BrakkeConsulting.com ********************************** COMPANY NEWS RELEASES \u2022 PharmAust announced an agreement with Elanco to develop monepantel, an antiparasitic drug for sheep and goats, to treat cancer in dogs and humans. Elanco will have first right to negotiate for the worldwide commercial license for PharmAust&#8217;s intellectual property in treating cancer in animals. Elanco will supply PharmAust&#8217;s next clinical trials of the drug in dogs. (news.com.au) \u2022 Dechra Veterinary Products announced the launch of Redonyl Ultra Soft Chews, a palatable veterinary nutraceuticalView Full Post;"}